Impact of Different Embolic Agents for Transarterial Chemoembolization (TACE) Procedures on Systemic Vascular Endothelial Growth Factor (VEGF) Levels

Background and Aims: Intermediate stage hepatocellular carcinoma (HCC) can be treated by transarterial chemoembolization (TACE). However, there appear to be side effects, such as induction of proangiogenic factors, e.g. vascular endothelial growth factor (VEGF), which have been shown to be associate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Transl Hepatol
Main Authors: Schicho, Andreas, Hellerbrand, Claus, Krüger, Kristina, Beyer, Lukas P., Wohlgemuth, Walter, Niessen, Christoph, Hohenstein, Ernst, Stroszczynski, Christian, Pereira, Philippe L., Wiggermann, Philipp
Formato: Artigo
Idioma:Inglês
Publicado em: XIA & HE Publishing Inc. 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5225147/
https://ncbi.nlm.nih.gov/pubmed/28097096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2016.00058
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados